Skip to Content
Diagnosed with Prostate Cancer? Learn about your treatment options >>

Bicalutamide Pregnancy and Breastfeeding Warnings

Bicalutamide is also known as: Casodex

Medically reviewed on Mar 27, 2017

Bicalutamide Pregnancy Warnings

Bicalutamide has been assigned to pregnancy category X by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Bicalutamide is contraindicated in women who are, or may become pregnant.

See references

Bicalutamide Breastfeeding Warnings

There are no data on the excretion of bicalutamide into human milk.

See references

References for pregnancy information

  1. "Product Information. Casodex (bicalutamide)." Zeneca Pharmaceuticals, Wilmington, DE.

References for breastfeeding information

  1. "Product Information. Casodex (bicalutamide)." Zeneca Pharmaceuticals, Wilmington, DE.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide